Catalyst Biosciences, Inc. (CBIO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 15.40M |
| Enterprise value | -58.57M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.78 |
| Price/book (mrq) | 0.19 |
| Enterprise value/revenue | -10.59 |
| Enterprise value/EBITDA | 0.89 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.35 |
| 52-week change 3 | -59.43% |
| S&P500 52-week change 3 | -16.03% |
| 52-week high 3 | 1.2280 |
| 52-week low 3 | 0.0920 |
| 50-day moving average 3 | 0.4953 |
| 200-day moving average 3 | 0.2943 |
Share statistics
| Avg vol (3-month) 3 | 3.61M |
| Avg vol (10-day) 3 | 2.35M |
| Shares outstanding 5 | 31.48M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 23.99M |
| % held by insiders 1 | 15.06% |
| % held by institutions 1 | 25.95% |
| Shares short (30 Aug 2022) 4 | 1.97M |
| Short ratio (30 Aug 2022) 4 | 4.27 |
| Short % of float (30 Aug 2022) 4 | 6.32% |
| Short % of shares outstanding (30 Aug 2022) 4 | 6.27% |
| Shares short (prior month 28 July 2022) 4 | 1.31M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 19 Sept 2022 |
| Ex-dividend date 4 | 20 Sept 2022 |
| Last split factor 2 | 3803:1000 |
| Last split date 3 | 20 Sept 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 June 2022 |
Profitability
| Profit margin | -153.10% |
| Operating margin (ttm) | -1,098.68% |
Management effectiveness
| Return on assets (ttm) | -41.04% |
| Return on equity (ttm) | -10.32% |
Income statement
| Revenue (ttm) | 5.53M |
| Revenue per share (ttm) | 0.18 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | -64.91M |
| EBITDA | -60.41M |
| Net income avi to common (ttm) | -8.47M |
| Diluted EPS (ttm) | -2.5480 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 75.39M |
| Total cash per share (mrq) | 2.39 |
| Total debt (mrq) | 1.42M |
| Total debt/equity (mrq) | 1.79 |
| Current ratio (mrq) | 18.86 |
| Book value per share (mrq) | 2.51 |
Cash flow statement
| Operating cash flow (ttm) | -63.62M |
| Levered free cash flow (ttm) | -42.32M |
© 2022 Yahoo. All rights reserved.
